
Kedrion specializes in plasma-derived therapies for treating rare diseases and immune deficiencies. Its products support healthcare providers in addressing patient needs globally.
2000
Italy
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$1M - 10M in profitability